Emory University School of Medicine, Atlanta, GA, USA.
Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA.
Neurocrit Care. 2019 Aug;31(1):142-161. doi: 10.1007/s12028-018-0645-2.
The aim of this study was to assess the current state of automated pupillometry technology and its application in the neurointensive care unit (neuroICU). We performed a literature search using the PubMed, MEDLINE, and EMBASE databases from database inception through a search end date of October 18, 2018, to identify studies reporting on the use of automated pupillometry in the care of critically ill patients with neurological impairment. Two independent reviewers reviewed all titles and abstracts in two filtering phases. Data were extracted independently. One hundred and forty-one articles/abstracts have been published on the use of automated pupillometry in critical care since inception of the PubMed, MEDLINE, and EMBASE databases. We selected and reviewed 22 full-text articles and 8 abstracts, of which 26 were prospective, 2 were retrospective, and 2 were larger case series. Automated pupillometry increased precision, reliability, and reproducibility compared with the manual pupillary examination; detected subtle and early pupillary changes; detected pupillary changes that indicate a rise, or impending rise, in intracranial pressure detected level of analgesia and depth of sedation; served as a prognostic indicator; estimated the clinical severity of aneurysmal subarachnoid hemorrhage; and served as a noninvasive monitor of response to osmotic therapy. At present, no consensus guidelines exist endorsing routine use of automated pupillometry in the neuroICU. However, an increasing quantity of research supports the usefulness of automated pupillometry in this setting. Further large-scale prospective studies are needed before updated consensus guidelines recommending widespread adoption of automated pupillometry are produced.
本研究旨在评估自动瞳孔计技术的现状及其在神经重症监护病房(neuroICU)中的应用。我们使用 PubMed、MEDLINE 和 EMBASE 数据库进行了文献检索,检索时间从数据库建立到 2018 年 10 月 18 日截止,以确定报告在神经重症监护中使用自动瞳孔计的研究。两名独立的审查员在两个过滤阶段审查了所有的标题和摘要。独立提取数据。自 PubMed、MEDLINE 和 EMBASE 数据库建立以来,已有 141 篇关于自动瞳孔计在重症监护中的应用的文章/摘要发表。我们选择并审查了 22 篇全文文章和 8 篇摘要,其中 26 篇是前瞻性的,2 篇是回顾性的,2 篇是较大的病例系列。与手动瞳孔检查相比,自动瞳孔计提高了精度、可靠性和可重复性;检测到细微和早期的瞳孔变化;检测到提示颅内压升高或即将升高的瞳孔变化;检测到镇痛和镇静深度;作为预后指标;估计蛛网膜下腔出血的临床严重程度;作为对渗透性治疗反应的无创监测。目前,没有共识指南支持在 neuroICU 中常规使用自动瞳孔计。然而,越来越多的研究支持自动瞳孔计在这种情况下的有用性。在提出推荐广泛采用自动瞳孔计的更新共识指南之前,需要进行更多的大规模前瞻性研究。